220 filings
Page 4 of 11
8-K
4q1wnbtprzyojuoo6j3
2 Jan 14
Departure of Directors or Certain Officers
12:00am
8-K
d451jey20af5uazqdqe
26 Dec 13
Entry into a Material Definitive Agreement
12:00am
8-K
68lnlu sd
13 Dec 13
Echo to receive a $10 million cash investment from MTIA and Platinum Partners
12:00am
8-K
x01a7xhrgcw8g15
15 Oct 13
Departure of Directors or Certain Officers
12:00am
8-K
arsl5j kq
3 Oct 13
Echo Therapeutics Provides Corporate Update and Implements Substantial Cost Reduction Initiatives
12:00am
8-K
rn7nuvamfpjpdl1s45z
29 Aug 13
Echo Therapeutics Announces Management Changes
12:00am
8-K
jitdzd00tdny
9 Aug 13
Echo Therapeutics Announces Second Quarter 2013 Financial Results
12:00am
8-K
lymnal89lj6k
28 Jun 13
Other Events
12:00am
8-K
j6iz8 1c614a3
19 Jun 13
Echo Therapeutics Announces Pricing of Public Offering of Common Stock
12:00am
8-K
7ikmuamjg xbf
10 Jun 13
Echo Therapeutics Submits Pre-Submission Package to FDA for Symphony® CGM System
12:00am
8-K
h2ivvg xv
7 Jun 13
Other Events
12:00am
8-K/A
rhyllfm11u9n
28 May 13
Echo Therapeutics Announces Successful Unveiling of Symphony® CGM System
12:00am
8-K
u0k5w6j 93ectzccvab
23 May 13
Echo Therapeutics Announces Successful Unveiling of Symphony® CGM System
12:00am
8-K
ng2sx
10 May 13
Echo Therapeutics Announces First Quarter 2013 Financial Results
12:00am
8-K
f0rk39zg3pj1l9vanj
22 Mar 13
Echo Therapeutics, Inc. Announces 2012 Financial Results
12:00am
8-K
rrum8 36aejd2
18 Mar 13
Echo Therapeutics Appoints Robert Doman to Board of Directors
12:00am
8-K
q5r 4fgz0h5
4 Feb 13
Echo Therapeutics Announces Pricing of Public Offering of Common Stock
12:00am
8-K
kz4ic4f2i
21 Dec 12
Echo Therapeutics Announces Pricing of Public Offering of Common Stock
12:00am
8-K
xbu8a
9 Nov 12
Echo Therapeutics Announces Third Quarter 2012 Financial Results
12:00am
8-K
xx1ar1z70 87b
7 Sep 12
Entry into a Material Definitive Agreement
12:00am